Skip to content
★ Sign in to follow
DR

David Rosal

CFO
HealthLynked Corp
Total declarations
2
Company
1
▲ Purchases (2 ops.)
€4,733
▼ Sales (0 ops.)
—

Latest filing published 24 Jun 2024 for HealthLynked Corp, €2,217.

Filing timeline

BuySale
David Rosal

Insider track record

Disclosed buys
2
Disclosed sells
0
Signal history

Closed purchases

Market purchases
2
Positive at T+90
0%
Median T+90
-46.2%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 24 Jun 2024 · 867 days ago · €2,217
    -76.3%
    Entry US$8.00 · Close at T+365 US$1.90

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

David Rosal: trading record in brief

David Rosal is a declared insider of HealthLynked Corp, with filings sourced from SEC (Form 4). The record holds 2 filings, for trades running from 20 June 2024 to 24 June 2024.

No open-market sale appears; the market trades are 2 purchases worth €4,733. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.

The latest filing, published on 24 June 2024, reports an open-market purchase of €2,217 in HealthLynked Corp. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to David Rosal

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ▲
    Chief Financial OfficerExecutivesHealthLynked Corp
    2,380 USD26SEC
    28,333 shares@ US$0.08446.9% of flowCommon stockSEC:0001213900-24-055207:1
    Canonical exit: 22 Sept 2024 (T+90)
  • ▲
    Chief Financial OfficerExecutivesHealthLynked Corp
    2,693 USD27SEC
    33,667 shares@ US$0.08100.0% of flowCommon stockSEC:0001213900-24-055207:0
    Canonical exit: 18 Sept 2024 (T+90)

2 of 2 declarations